LIFECARE ASA (LIFE.OL) Stock Fundamental Analysis
Europe - OSL:LIFE - NO0013355859 - Common Stock
5.56 NOK
+0.04 (+0.72%)
LIFE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 62 industry peers in the Health Care Equipment & Supplies industry. LIFE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, LIFE is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
LIFE had negative earnings in the past year.
In the past year LIFE has reported a negative cash flow from operations.
In the past 5 years LIFE always reported negative net income.
In the past 5 years LIFE always reported negative operating cash flow.
1.2 Ratios
LIFE has a worse Return On Assets (-92.41%) than 95.16% of its industry peers.
Looking at the Return On Equity, with a value of -123.73%, LIFE is doing worse than 87.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.41% | ||
| ROE | -123.73% | ||
| ROIC | N/A |
ROA(3y)-42.56%
ROA(5y)-38.96%
ROE(3y)-60.43%
ROE(5y)-53.27%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for LIFE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
LIFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LIFE has more shares outstanding than it did 1 year ago.
LIFE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for LIFE has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -1.24, we must say that LIFE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.24, LIFE is doing worse than 83.87% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that LIFE is not too dependend on debt financing.
The Debt to Equity ratio of LIFE (0.12) is better than 72.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.24 |
ROIC/WACCN/A
WACC7.94%
2.3 Liquidity
A Current Ratio of 3.23 indicates that LIFE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.23, LIFE belongs to the top of the industry, outperforming 85.48% of the companies in the same industry.
LIFE has a Quick Ratio of 3.23. This indicates that LIFE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.23, LIFE belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.23 | ||
| Quick Ratio | 3.23 |
3. Growth
3.1 Past
LIFE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.51%.
The Revenue for LIFE has decreased by -26.10% in the past year. This is quite bad
LIFE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.13% yearly.
EPS 1Y (TTM)-41.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.67%
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-99.84%
3.2 Future
The Earnings Per Share is expected to grow by 5.53% on average over the next years.
The Revenue is expected to grow by 45.55% on average over the next years. This is a very strong growth
EPS Next Y4.06%
EPS Next 2Y4.9%
EPS Next 3Y5.53%
EPS Next 5YN/A
Revenue Next Year-50%
Revenue Next 2Y8.01%
Revenue Next 3Y45.55%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
LIFE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LIFE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.9%
EPS Next 3Y5.53%
5. Dividend
5.1 Amount
No dividends for LIFE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OSL:LIFE (10/30/2025, 7:00:00 PM)
5.56
+0.04 (+0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners7.56%
Inst Owner ChangeN/A
Ins Owners7.41%
Ins Owner ChangeN/A
Market Cap105.97M
Revenue(TTM)2.83M
Net Income(TTM)-73000000
AnalystsN/A
Price Target36.72 (560.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-23.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-66.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 37.45 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.8 | ||
| P/tB | 2.26 | ||
| EV/EBITDA | N/A |
EPS(TTM)-16.5
EYN/A
EPS(NY)-4.29
Fwd EYN/A
FCF(TTM)-4.26
FCFYN/A
OCF(TTM)-3.67
OCFYN/A
SpS0.15
BVpS3.1
TBVpS2.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.41% | ||
| ROE | -123.73% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-42.56%
ROA(5y)-38.96%
ROE(3y)-60.43%
ROE(5y)-53.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 196.31% | ||
| Cap/Sales | 394.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.23 | ||
| Quick Ratio | 3.23 | ||
| Altman-Z | -1.24 |
F-Score1
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)169.82%
Cap/Depr(5y)N/A
Cap/Sales(3y)56.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.67%
EPS Next Y4.06%
EPS Next 2Y4.9%
EPS Next 3Y5.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-99.84%
Revenue Next Year-50%
Revenue Next 2Y8.01%
Revenue Next 3Y45.55%
Revenue Next 5YN/A
EBIT growth 1Y-142.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.11%
EBIT Next 3Y7.32%
EBIT Next 5YN/A
FCF growth 1Y-193.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-167.23%
OCF growth 3YN/A
OCF growth 5YN/A
LIFECARE ASA / LIFE.OL FAQ
What is the ChartMill fundamental rating of LIFECARE ASA (LIFE.OL) stock?
ChartMill assigns a fundamental rating of 3 / 10 to LIFE.OL.
What is the valuation status for LIFE stock?
ChartMill assigns a valuation rating of 0 / 10 to LIFECARE ASA (LIFE.OL). This can be considered as Overvalued.
How profitable is LIFECARE ASA (LIFE.OL) stock?
LIFECARE ASA (LIFE.OL) has a profitability rating of 0 / 10.
Can you provide the financial health for LIFE stock?
The financial health rating of LIFECARE ASA (LIFE.OL) is 5 / 10.